Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Amortization - Deferred ChargesCost of RevenueEBIATGross ProfitMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Fennec Pharmaceuticals (FENC) Amortization - Deferred Charges (2019 - 2025)

Fennec Pharmaceuticals filings provide 7 years of Amortization - Deferred Charges readings, the most recent being $26000.0 for Q4 2025.

  • On a quarterly basis, Amortization - Deferred Charges rose 4.0% to $26000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $64000.0, a 28.09% decrease, with the full-year FY2025 number at $64000.0, down 28.09% from a year prior.
  • Amortization - Deferred Charges hit $26000.0 in Q4 2025 for Fennec Pharmaceuticals, up from $12000.0 in the prior quarter.
  • In the past five years, Amortization - Deferred Charges ranged from a high of $73000.0 in Q2 2023 to a low of $7000.0 in Q1 2022.
  • Median Amortization - Deferred Charges over the past 5 years was $23000.0 (2024), compared with a mean of $35117.6.
  • Biggest five-year swings in Amortization - Deferred Charges: plummeted 97.75% in 2021 and later surged 928.57% in 2023.
  • Fennec Pharmaceuticals' Amortization - Deferred Charges stood at $8000.0 in 2021, then soared by 775.0% to $70000.0 in 2022, then changed by 0.0% to $70000.0 in 2023, then crashed by 64.29% to $25000.0 in 2024, then grew by 4.0% to $26000.0 in 2025.
  • The last three reported values for Amortization - Deferred Charges were $26000.0 (Q4 2025), $12000.0 (Q3 2025), and $13000.0 (Q2 2025) per Business Quant data.